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Type 2 diabetes is a major chronic disease with an increasing 
incidence and prevalence, due to population growth, age-
ing, and the large rise in the prevalence of obesity caused 
by unhealthy diets and a lack of physical activity. Adequate 
treatment of type 2 diabetes is important to prevent or 
delay the onset of severe micro- and macrovascular com-
plications, like cardiovascular disease.  Due to the chronic 
character of the disease, diabetes care is complex and does 
not only involve treatment with medication, but also dealing 
with psychological problems, and a change of dietary intake 
and physical activity.
Disease management is believed to have a high potential to 
improve patients’ outcomes above the classical healthcare 
system. Disease management is defined as ‘a systematic, 
population-based approach to identify persons at risk, in-
tervene with specific programs of care, and measure clinical 
and other outcomes’. The main element of disease manage-
ment is patient empowerment, which is defined as ‘helping 
people to discover and use their own ability to gain mastery 
over their disease’. It is known that disease management 
works in experimental settings but it is unclear if it is 
effective on the long term and in real-life settings. In addi-
tion,  evidence on interventions focused on the increase of 
patients’ self-management of diabetes is inconclusive.
Therefore, the aim of the present thesis was to gain more 
insight into disease management and patient empower-
ment for patients with type 2 diabetes.
